Haematologica, Vol 92, Issue 7, 996-997 doi:10.3324/haematol.11019
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dawson, M. A.
Right arrow Articles by Cole-Sinclair, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dawson, M. A.
Right arrow Articles by Cole-Sinclair, M. F.

Acute Myeloid Leukmia

Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough?

Mark A. Dawson*,#,, Sharon Avery*, Zoe K. McQuilten*, Michael J. Bailey°, Jake Shortt*,#, Mark N. Polizzotto*,#, Erica M. Wood#, Merrole F. Cole-Sinclair*

* Clinical Haematology/Bone Marrow Transplant Unit and Haematology Unit, Alfred Pathology Service, The Alfred Melbourne
° Department of Epidemiology and Preventive Medicine, Monash University, The Alfred, Melbourne;
# Australian Red Cross Blood Service, Melbourne, Victoria, Australia

Correspondence: Mark A. Dawson, The Alfred, Commercial Road, Melbourne, Victoria, Australia 3004. Phone: international +61.392762000. Fax: international +61.392763021. E-mail: dawsonm{at}ausdoctors.net

Although essential in the management of AML, there is little information quantitating transfusion requirements for these patients. We evaluated 111 consecutive adults treated for AML, showing that approximately 150 blood donors are required to adequately cater for a single patient’s complete therapy with little variation for age, prognostic group or intensity of treatment.

Key words: blood transfusion, chemotherapy, acute myeloid leukemia.